Back
CBRE Group Vs. Aligos Therapeutics Industry Stock Comparison
Buy
79
CBRE
CBRE Group
Last Price:
138.21
Seasonality Move:
7.88%
Buy
74
ALGS
Aligos Therapeutics
Last Price:
32.24
Seasonality Move:
10.65%
Buy
79
CBRE Group (CBRE)
is a Buy
Is CBRE Group a Buy, Sell or Hold?
- The current CBRE Group [CBRE] share price is $135.88. The Score for CBRE is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- CBRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CBRE Stock Price Chart
What is CBRE Group's stock price today?
-
The CBRE Group share price today is $135.88
The current trend is moderately bullish and CBRE is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CBRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2 | Buy |
Relative Strength Index (14 RSI): | 53.09 | Buy |
Chaikin Money Flow: | -1062933 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.21 - 138.51) | Buy |
Bollinger Bands (100): | (111.18 - 132.48) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.32 | Buy |
Relative Strength Index (14 RSI): | 81.62 | Buy |
Chaikin Money Flow: | 315379 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.3 - 26.46) | Buy |
Bollinger Bands (100): | (7.85 - 19.03) | Buy |
CBRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 137.59 | Sell |
20-day SMA: | 135.79 | Buy |
50-day SMA: | 130.41 | Buy |
200-day SMA: | 106.07 | Buy |
8-day EMA: | 137.07 | Sell |
20-day EMA: | 135.77 | Buy |
50-day EMA: | 130.58 | Buy |
200-day EMA: | 110.88 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.35 | Buy |
20-day SMA: | 22.81 | Buy |
50-day SMA: | 14.24 | Buy |
200-day SMA: | 15.81 | Buy |
8-day EMA: | 27.13 | Buy |
20-day EMA: | 22.88 | Buy |
50-day EMA: | 17.49 | Buy |
200-day EMA: | 15.94 | Buy |
CBRE Group Earnings Growth & CBRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and an increase next year of $1.09 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
CBRE Group Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |